Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01532219
Other study ID # GA-DEPANX2012-APT
Secondary ID
Status Completed
Phase N/A
First received February 9, 2012
Last updated April 23, 2013
Start date February 2012
Est. completion date December 2012

Study information

Verified date April 2013
Source Linkoeping University
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with major depression and/or anxiety disorders and compare its efficacy to an active control group.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, Generalized Anxiety disorder, Depressive Disorder NOS or Anxiety Disorder NOS

- 10 or higher on the PHQ-9 or on the GAD-7 at pre-treatment

Exclusion Criteria:

- Primary diagnosis of Obsessive Compulsive Disorder or Post-traumatic Stress Disorder

- Severe psychiatric condition (e.g. psychosis or bipolar disorder)

- Alcohol abuse (more than 16 on the AUDIT)

- Suicidal (measured in diagnostic interview)

- Changed medication during the last three months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Internet-delivered Psychodynamic Treatment
Ten weeks of guided self-help + therapist contact, via the Internet.
Internet-delivered structured support
Ten weeks of therapist contact, via the Internet.

Locations

Country Name City State
Sweden Linköping University, Department of Behavioral Sciences and Learning Linköping

Sponsors (1)

Lead Sponsor Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary 9-item Patient Health Questionnaire Depression Scale (PHQ-9) Two weeks before the treatment starts No
Primary 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7) Two weeks before the treatment starts No
Primary 9-item Patient Health Questionnaire Depression Scale (PHQ-9) At treatment start (0 weeks) No
Primary 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7) At treatment start (0 weeks) No
Primary 9-item Patient Health Questionnaire Depression Scale (PHQ-9) At treatment termination (10 weeks) No
Primary 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7) At treatment termination (10 weeks) No
Primary 9-item Patient Health Questionnaire Depression Scale (PHQ-9) At treatment follow-up (7 months) No
Primary 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7) At treatment follow-up (7 months) No
Secondary Emotional Processing Scale (EPS-25) Two weeks before the treatment starts No
Secondary Emotional Processing Scale (EPS-25) At treatment start (0 weeks) No
Secondary Emotional Processing Scale (EPS-25) At treatment termination (10 weeks) No
Secondary Five Facets of Mindfulness Questionnaire (FFMQ) Two weeks before the treatment starts No
Secondary Five Facets of Mindfulness Questionnaire (FFMQ) At treatment start (0 weeks) No
Secondary Five Facets of Mindfulness Questionnaire (FFMQ) At treatment termination (10 weeks) No
Secondary Emotional Processing Scale (EPS-25) At treatment follow-up (7 months) No
Secondary Five Facets of Mindfulness Questionnaire (FFMQ) At treatment follow-up (7 months) No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A